Intuitive Surgical (ISRG) Stock Forecast & Price Target

$542.10 +5.55 (+1.03%)

(As of 11/26/2024 ET)

Intuitive Surgical - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 19 Analyst Ratings

Sell
1

Hold
4

Buy
14

Based on 19 Wall Street analysts who have issued ratings for Intuitive Surgical in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 1 has given a sell rating, 4 have given a hold rating, and 14 have given a buy rating for ISRG.

Consensus Price Target

$526.06
-2.96% Downside

According to the 19 analysts' twelve-month price targets for Intuitive Surgical, the average price target is $526.06. The highest price target for ISRG is $604.00, while the lowest price target for ISRG is $375.00. The average price target represents a forecasted downside of -2.96% from the current price of $542.10.

Get the Latest News and Ratings for ISRG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Intuitive Surgical and its competitors.

ISRG Analyst Ratings Over Time

Type	Current Forecast 11/27/23 to 11/26/24	1 Month Ago 10/28/23 to 10/27/24	3 Months Ago 8/29/23 to 8/28/24	1 Year Ago 11/27/22 to 11/27/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	14 Buy rating(s)	14 Buy rating(s)	15 Buy rating(s)	17 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	5 Hold rating(s)	4 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$526.06	$513.74	$446.45	$342.71
Forecasted Upside	-2.96% Downside	0.48% Upside	-7.42% Downside	8.81% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Video: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You (Ad)

“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up to a location just a few miles from here to show you Elon Musk’s next AI product. I promise what happens next will shock you…”

Click here to see what happened

ISRG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ISRG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Intuitive Surgical Stock vs. The Competition

Type	Intuitive Surgical	Medical Companies	S&P 500
Consensus Rating Score	2.68	2.80	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	-2.99% Downside	24,931.24% Upside	6.94% Upside
News Sentiment Rating	Positive News See Recent ISRG News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/26/2024	BTIG Research 2 of 5 stars		Boost Target	Buy ➝ Buy	$535.00 ➝ $561.00	+3.85%
11/19/2024	Erste Group Bank 3 of 5 stars		Upgrade	Hold ➝ Buy
10/18/2024	The Goldman Sachs Group 2 of 5 stars	David Roman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		$604.00	+15.73%
10/18/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Market Perform ➝ Market Perform
10/18/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Cautious ➝ Cautious
10/18/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$466.00 ➝ $549.00	+7.06%
The #1 Crypto for AI (Ad) We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.” Learn more about it by watching THIS NOW.
10/18/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rick Wise Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$475.00 ➝ $525.00	+2.38%
10/18/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$495.00 ➝ $538.00	+4.92%
10/18/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Shagun Singh Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$525.00 ➝ $555.00	+8.40%
10/17/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Anthony Petrone Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		$440.00 ➝ $500.00	+5.30%
10/17/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$489.00 ➝ $502.00	+5.72%
10/17/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$503.00 ➝ $565.00	+18.98%
10/14/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$500.00 ➝ $540.00	+11.06%
10/14/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Richard Newitter Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$520.00 ➝ $570.00	+17.78%
10/11/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$495.00 ➝ $575.00	+18.52%
8/22/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$512.00 ➝ $560.00	+14.31%
8/2/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Ridley-Day Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$380.00 ➝ $510.00	+13.10%
7/18/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$430.00 ➝ $490.00	+17.49%
7/15/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$375.00 ➝ $460.00	+5.42%
4/19/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$365.00 ➝ $375.00	+0.64%
11/17/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$318.00	+4.62%
10/19/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$385.00 ➝ $314.00	+14.82%
5/31/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$350.00 ➝ $365.00	+18.87%
4/19/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold	$245.00 ➝ $290.00	-4.27%
4/19/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$300.00 ➝ $315.00	+16.98%
3/23/2023	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Vazquez Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform
12/22/2022	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$265.00 ➝ $320.00	+20.23%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 05:12 PM ET.

Should I Buy Intuitive Surgical Stock? ISRG Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, November 22, 2024. Please send any questions or comments about these Intuitive Surgical pros and cons to contact@marketbeat.com.

Intuitive Surgical
Bull Case

Here are some ways that investors could benefit from investing in Intuitive Surgical, Inc.:

Intuitive Surgical, Inc. reported strong quarterly earnings, with earnings per share (EPS) of $1.56, exceeding the consensus estimate of $1.24. This indicates robust financial performance and potential for future growth.
The stock is currently priced at $538.79, which is near its 1-year high of $551.78, suggesting strong market confidence and potential for further appreciation.
Analysts have a consensus rating of "Moderate Buy" for the stock, with an average target price of $524.61, indicating positive sentiment among market experts.
Recent price targets from various analysts have been raised, with Royal Bank of Canada setting a target of $555.00, reflecting optimism about the company's future performance.
Intuitive Surgical, Inc. has a high net margin of 28.51%, which demonstrates its efficiency in converting revenue into profit, making it an attractive investment for those seeking profitable companies.

Intuitive Surgical
Bear Case

Investors should be bearish about investing in Intuitive Surgical, Inc. for these reasons:

Insider selling has been significant, with over 91,178 shares sold in the last quarter, which may indicate a lack of confidence from those closest to the company.
The stock has a high price-to-earnings (P/E) ratio of 86.63, suggesting that it may be overvalued compared to its earnings, which could deter value-focused investors.
Despite strong earnings, the company has a relatively low return on equity of 13.41%, which may raise concerns about how effectively it is using shareholder equity to generate profits.
Market volatility, indicated by a beta of 1.39, suggests that the stock may experience larger price fluctuations compared to the overall market, which could be a risk for conservative investors.
With only 0.90% of the stock owned by insiders, there may be less alignment between management and shareholder interests, which can be a red flag for potential investors.

ISRG Forecast - Frequently Asked Questions

: According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Intuitive Surgical is $526.06, with a high forecast of $604.00 and a low forecast of $375.00.
: 19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Intuitive Surgical in the last year. There is currently 1 sell rating, 4 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ISRG shares.
: According to analysts, Intuitive Surgical's stock has a predicted downside of -2.96% based on their 12-month stock forecasts.
: Over the previous 90 days, Intuitive Surgical's stock had 1 upgrade by analysts.
: Intuitive Surgical has been rated by research analysts at BTIG Research, Erste Group Bank, Evercore ISI, JPMorgan Chase & Co., Leerink Partners, Mizuho, Oppenheimer, Piper Sandler, Raymond James, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, The Goldman Sachs Group, Truist Financial, and Wells Fargo & Company in the past 90 days.
: Analysts like Intuitive Surgical less than other "medical" companies. The consensus rating score for Intuitive Surgical is 2.68 while the average consensus rating score for "medical" companies is 2.80. Learn more on how ISRG compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

This page (NASDAQ:ISRG) was last updated on 11/26/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Intuitive Surgical (ISRG) Stock Forecast & Price Target